US2003065021A1PendingUtilityA1

Tracheal smooth muscle relaxants

Priority: Jan 19, 1996Filed: Oct 1, 2002Published: Apr 3, 2003
Est. expiryJan 19, 2016(expired)· nominal 20-yr term from priority
C07D 337/14A61P 21/02A61K 31/382C07D 313/14A61K 31/38C07D 337/16A61K 31/335
45
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention offers a tracheal smooth muscle relaxant containing the compound represented by the following formula (1) or pharmacologically acceptable salt thereof as an effective ingredient. [In the formula, X and Y each is any group selected from a group consisting of CH 2 , CHW 1 (where W 1 is halogen atom, hydroxyl group or lower alkoxy group) and C═O when the bond of X and Y is a single bond while, when it is a double bond, X and Y each is any group selected from a group consisting of CH and COW 2 (where W 2 is lower alkyl group or lower alkylcarbonyl group); Z is O, S, S═O or SO 2 ; and R 1 ˜R 8 each is selected from a group consisting of hydrogen atom, VR 9 (where V is O, S, S═O or SO 2 ; and R 9 is hydrogen atom, lower alkyl group, hydroxy lower alkyl group, lower acyl group, trihalomethyl group or carboxyl lower alkyl group), carboxyl lower alkyl group, hydroxy lower alkyl group, hydroxy lower alkenyl group, hydroxy lower alkynyl group, halogen atom, lower alkyl group, lower alkyl ketone, trihalomethyl group, trimethylsilylethynyl, nitro group, amino group, N-carbonyl lower alkyl group, lower alkylphenyl group and phenyl group].

Claims

exact text as granted — not AI-modified
We claim:  
     
         1 . A compound represented by formula (1):  
       
         
           
           
               
               
           
         
       
       wherein 
 X and Y each is any member selected from the group consisting of CH 2 , CHW 1 , (where W 1  is a halogen atom, a hydroxyl group or a lower alkoxy group) and C═O when the bond between X and Y is a single bond while, when the bond between X and Y is a double bond, X and Y each is any member selected from the group consisting of CH and COW 2  (where W 2  is a lower alkyl group or a lower alkylcarbonyl group);  
 Z is O, S, S═O or SO 2 ; and  
 R 1 -R 8  each is selected from the group consisting of a hydrogen atom, VR 9  (where V is O, S, S═O or SO 2 ; and R 9  is a hydrogen atom, a lower alkyl group, a hydroxy lower alkyl group, a lower acyl group, a trihalomethyl group or a carboxyl lower alkyl group), a carboxyl lower alkyl group, a hydroxy lower alkyl group, a hydroxy lower alkenyl group, a hydroxy lower alkynyl group, a halogen atom, a lower alkyl group, a lower alkyl ketone, a trihalomethyl group, a trimethylsilylethynyl group, a nitro group, an amino group, an N-carbonyl lower alkyl group, a lower alkylphenyl group and a phenyl group or a pharmaceutically acceptable salt thereof.

Join the waitlist — get patent alerts

Track US2003065021A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.